drugset / Trial / NCT04886960

pAF for the Treatment of Osteoarthritis

NCT04886960 ↗

Phase 1/2 Completed 60 enrolled University of Utah
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a Phase I/II Randomized Double-Blinded Standard of Care (Corticosteroid) vs. Sterile Amniotic Fluid for Osteoarthritis

Timeline

Start
2021-07-08
Primary completion
2025-01-31
Completion
2025-01-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amniotic Fluid Injection Unknown 3 ml Other

Indications